why choose us

First received: August 01, 2022

Clinical Trial: Zemaira Eosinophilic Esophagitis Pilot Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Eosinophilic Esophagitis

Study Type: INTERVENTIONAL


Official Title: An Open-Label Study of Zemaira (Alpha 1-Trypsin Inhibitor) in Subjects With Eosinophilic Esophagitis

Brief Summary: This is a prospective, open-label drug study that will examine the effects of Zemaira (alpha-1 trypsin inhibitor) in patients with Eosinophilic Esophagitis.

Read more